Abstracts
AUTHOR/PRESENTER | YEAR | TITLE | VENUE |
---|---|---|---|
Westerveld, Aimée | 2023 | Long-term Risk of Subsequent Malignant and Benign Neoplasms After Childhood Neuroblastoma: A DCCSS-LATER 3 Study | ISLCCC 2023, Atlanta, USA |
Wang, Yuehan | 2023 | Risk of subsequent breast cancer associated with chest radiation field and dose among female childhood cancer survivors: a report from the International Consortium for Pooled Studies on Subsequent Malignancies | ISLCCC 2023, Atlanta, USA |
Teepen, Jop | 2023 | Incidence, risk factors, and clinical characteristics of cerebrovascular events among childhood cancer survivors treated with upper body radiotherapy in the DCCSS-LATER cohort | ISLCCC 2023, Atlanta, USA |
Houtman, Bente | 2023 | Treatments affecting splenic function as a risk factor for valvular heart disease in Childhood Cancer Survivors; a DCCSS-LATER study | ISLCCC 2023, Atlanta, USA |
Priboi, Cristina | 2023 | Psychosexual development, sexual functioning and sexual satisfaction in long term childhood cancer survivors: DCCSS-LATER 2 Sexuality Substudy | European Society for Sexual Medicine congress Rotterdam, The Netherlands |
Maas, Anne | 2023 | Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology study | SIOP 2023, Ottawa, USA |
Priboi, Cristina | 2023 | Psychosexual development, sexual functioning and sexual satisfaction in long term childhood cancer survivors: DCCSS-LATER 2 Sexuality Substudy | Research Symposium Health Lucerne, Switzerland |
Atteveld, Jenneke | 2022 | Frailty and sarcopenia and the association with bone mineral density within the earliest national Dutch childhood cancer survivor cohort: a DCCSS-LATER 2 Study | American Society of Hematology (ASH) Annual Meeting and Exposition, New Orleans, LA, USA. |
Atteveld, Jenneke | 2022 | Risk and determinants of reduced bone mineral density and fractures in a national cohort of Dutch childhood cancer survivors: a DCCSS-LATER 2 study | American Society of Hematology (ASH) Annual Meeting and Exposition, New Orleans, LA, USA. |
Penson, Adriaan | 2022 | The impact of cancer-related fatigue on HRQOL in long-term survivors of childhood cancer; a DCCSS-LATER study | First International Cancer Survivor Symposium, Bern, Switzerland |
Feijen, Lieke | 2022 | Detection of abnormal values of cardiac function and associated markers in childhood cancer survivors: a cross-sectional study | First International Pediatric Cardio-Oncology Conference, Cincinnati OH, USA |
Atteveld, Jenneke | 2022 | Frailty and sarcopenia and the association with bone mineral density within the earliest national Dutch childhood cancer survivor cohort: a DCCSS-LATER 2 Study | International Conference on Children’s Bone Health, Dublin, Ireland |
Atteveld, Jenneke | 2022 | Risk and determinants of reduced bone mineral density and fractures in a national cohort of Dutch childhood cancer survivors: a DCCSS-LATER 2 study | International Conference on Children’s Bone Health, Dublin, Ireland |
Kooijmans, Esmee | 2022 | Long-term glomerular dysfunction in childhood cancer survivors; DCCSS-LATER 2 Renal study | IPNA, Calgary, Canada |
Claessens, Joyce | 2022 | Desire for children and use of reproductive health care among male survivors of childhood cancer: a DCCSS-LATER 1 study | ISLCCC 2022, Utrecht, The Netherlands |
De Baat, Esmee | 2022 | Risk factors for heart failure among Pan-European childhood cancer survivors: a PanCareSurFup & ProCardio cohort and nested case-control study | ISLCCC 2022, Utrecht, The Netherlands |
Kooijmans, Esmee | 2022 | Long-term glomerular dysfunction in childhood cancer survivors; DCCSS-LATER 2 Renal study | ISLCCC 2022, Utrecht, The Netherlands |
Leerink, Jan | 2022 | Blood biomarkers for ruling out cardiac dysfunction in childhood cancer survivors: A report from the Dutch Childhood Cancer Survivor Study (DCCSS-LATER 2 CARD). | ISLCCC 2022, Utrecht, The Netherlands |
Maas, Anne | 2022 | Psychosocial outcomes in long-term dutch adult survivors of childhood cancer: the DCCSS-LATER 2 psycho-oncology study | ISLCCC 2022, Utrecht, The Netherlands |
Merkx, Remy | 2022 | Echocardiographic Similarity of Childhood Cancer Survivors and their Siblings Using Machine Learning: Results from the DCCSS-LATER 2 CARD Study. | ISLCCC 2022, Utrecht, The Netherlands |
Penson, Adriaan | 2022 | Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire – a DCCSS-LATER study | ISLCCC 2022, Utrecht, The Netherlands |
Priboi, Cristina | 2022 | Sexual experience, sexual functioning and sexual satisfaction in childhood cancer survivors | ISLCCC 2022, Utrecht, The Netherlands |
Stolze, Juliette | 2022 | Prevalence and risk factors for hyposalivation and xerostomia in childhood cancer survivors – a LATER-2 DCCSS Clinical Study | ISLCCC 2022, Utrecht, The Netherlands |
Streefkerk, Nina | 2022 | The cumulative burden of symptomatic outcomes in long-term childhood cancer survivors and implications for survivorship care: a DCCSS-LATER study | ISLCCC 2022, Utrecht, The Netherlands |
Verburggen, Lisanne | 2022 | Incidence and clinical characteristics of cerebrovascular events among long- term childhood cancer survivors treated with upper body radiation therapy in the DCCSS-LATER cohort | ISLCCC 2022, Utrecht, The Netherlands |
Wang, Yuehan | 2022 | Anthracycline-associated risk of subsequent breast cancer in female childhood cancer survivors: a report from the International Consortium for Pooled Studies on Subsequent Malignancies | ISLCCC 2022, Utrecht, The Netherlands |
Van Kalsbeek, Rebecca | 2022 | Late pulmonary dysfunction in childhood cancer survivors treated with cyclophosphamide – a Dutch population-based cohort study | PanCare Budapest, Hungary |
Atteveld, Jenneke | 2022 | Frailty and sarcopenia and the association with bone mineral density within the earliest national Dutch childhood cancer survivor cohort: a DCCSS-LATER 2 Study | SIOP 2022, Barcelona, Spain. |
Bouwman, Eline | 2022 | Prevalence and risk factors of unhealthy lifestyle behaviors among survivors of childhood cancer in the netherlands; a DCCSS-LATER 1 questionnaire study | SIOP 2022, Barcelona, Spain. |
Claessens, Joyce | 2022 | Desire for children and use of reproductive health care among male survivors of childhood cancer: a DCCSS-LATER 1 study | SIOP 2022, Barcelona, Spain. |
Maas, Anne | 2022 | Psychosocial outcomes in long-term dutch adult survivors of childhood cancer: the DCCSS-LATER 2 psycho-oncology study | SIOP 2022, Barcelona, Spain. |
Merkx, Remy | 2022 | SYSTOLIC dysfunction in childhood cancer survivors on echocardiography: sex-specific Effects and risk beyond cardiotoxic exposures. Results from the DCCSS-LATER 2 CARD Study. | SIOP 2022, Barcelona, Spain. |
Penson, Adriaan | 2022 | The impact of cancer-related fatigue on HRQOL in long-term survivors of childhood cancer; a DCCSS-LATER study | SIOP 2022, Barcelona, Spain. |
Penson, Adriaan | 2022 | Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire – a DCCSS-LATER study | SIOP 2022, Barcelona, Spain. |
Verburggen, Lisanne | 2022 | Incidence and clinical characteristics of cerebrovascular events among long-term childhood cancer survivors treated with upper body radiation therapy in the DCCSS LATER cohort | SIOP 2022, Barcelona, Spain. |
Kooijmans, Esmee | 2021 | Hypertension in childhood cancer survivors after treatment with potentially nephrotoxic therapy and the added value of ambulatory blood pressure monitoring; dccss-later 2: rena. | ESPN, Amsterdam, The Netherlands |
Kooijmans, Esmee | 2021 | Tubular dysfunction and treatment-related risk factors in long-term childhood cancer survivors; DCCSS-LATER 2: rena. | ESPN, Amsterdam, The Netherlands |
Kooijmans, Esmee | 2021 | Hypertension in childhood cancer survivors after treatment with potentially nephrotoxic therapy and the added value of ambulatory blood pressure monitoring; dccss-later 2: rena. | SIOP 2021, online congress |
Kooijmans, Esmee | 2021 | Tubular dysfunction and treatment-related risk factors in long-term childhood cancer survivors; DCCSS-LATER 2: rena. | SIOP 2021, online congress |
Maas, Anne | 2021 | Psychosocial developmental trajectory of young adult survivors of childhood cancer: survivors of central nervous system cancer at risk | SIOP 2021, online congress |
van Gorp, Marloes | 2021 | Psychosocial functioning of parents of dutch long-term survivors of childhood cancer | SIOP 2021, online congress |
van Gorp, Marloes | 2021 | Impaired health-related quality of life of male and female survivors of childhood cancer: results from the DCCSS-LATER 2 psycho-oncology study | SIOP 2021, online congress |
Meijer, Annelot | 2020 | Risk Factors associated with Tinnitus in 2,948 Dutch Survivors of Childhood Cancer: a Dutch LATER questionnaire study | ? |
Leerink, Jan | 2020 | Plasma markers for detection of anthracycline-induced cardiomyopathy in childhood cancer survivors: A nested case-control study in the Dutch LATER cohort study. | ESC, Amsterdam, The Netherlands |
Merkx, Remy | 2020 | Cardiac Function in Childhood Cancer Survivors Treated with Vincristine: Echocardiographic Results from the DCCSS-LATER 2 CARD Study. | ESC, Amsterdam, The Netherlands |
Leerink, Jan | 2019 | Targeted proteomics to identify early diagnostic biomarkers for anthracycline-induced cardiomyopathy in long-term survivors of childhood cancer. | HFSA, Philadelphia PA, USA |
Feijen, Lieke | 2019 | High risk of symptomatic cardiac ischemia in a pan-european cohort of childhood cancer survivors: a pancaresurfup study | NASLCCC 2019, Atlanta GA, USA |
Kok, Judith | 2019 | Radiotherapy experience of long-term childhood cancer survivors in the netherlands: characteristics and temporal trends (1963-2001). DCOG-LATER cohort | NASLCCC 2019, Atlanta GA, USA |
Kooijmans, Esmee | 2019 | Hypertension in childhood cancer survivors treated with potentially nephrotoxic therapy: evaluation of prevalence, risk factors and the use of 24-hour ambulatory blood pressure measurement, a DCOG-LATER study | NASLCCC 2019, Atlanta GA, USA |
Kooijmans, Esmee | 2019 | Hypertension in childhood cancer survivors treated with potentially nephrotoxic therapy: evaluation of prevalence, risk factors and the use of 24-hour ambulatory blood pressure measurement, a DCOG-LATER study | NASLCCC 2019, Atlanta GA, USA |
Leerink, Jan | 2019 | Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: methodological aspects of the cross-sectional cardiac DCOG-LATER study | NASLCCC 2019, Atlanta GA, USA |
Leerink, Jan | 2019 | The value of left ventricular ejection fraction at first long-term follow-up echocardiogram in the screening for cardiomyopathy in long-term survivors of childhood cancer. | NASLCCC 2019, Atlanta GA, USA |
Leerink, Jan | 2019 | Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: methodological aspects of the cross-sectional cardiac DCOG-LATER study. | NASLCCC 2019, Atlanta GA, USA |
Merkx, Remy | 2019 | Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: methodological aspects of the cross-sectional cardiac DCOG-LATER study. | NASLCCC 2019, Atlanta GA, USA |
Reulen, Raoul | 2019 | 230 subsequent primary bone tumours in 69,460 survivors of childhood cancer: pan-european pooled nested case-control study within pancaresurfup | NASLCCC 2019, Atlanta GA, USA |
Streefkerk, Nina | 2019 | High hospitalization rates in 5,650 long-term childhood cancer survivors: a DCOG-LATER linkage study | NASLCCC 2019, Atlanta GA, USA |
Teepen, Jop | 2019 | Long-term risk of skin cancer among childhood cancer survivors: a DCOG-LATER cohort study | NASLCCC 2019, Atlanta GA, USA |
Verbruggen, Lisanne | 2019 | Epidemiology and clinical characteristics of subsequent meningiomas among longterm childhood cancer survivors: a DCOG-LATER study | NASLCCC 2019, Atlanta GA, USA |
Kok, Judith | 2019 | Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age | PALGA prijs, The Netherlands |
Leerink, Jan | 2018 | Evolution of asymptomatic left ventricular dysfunction in 380 long-term survivors of childhood cancer | HFSA, Nashville TN, USA |
Teepen, Jop | 2017 | Histologically-confirmed colorectal adenoma after childhood cancer treatment: a DCOG-LATER record linkage study | NASLCCC 2017, Atlanta, USA |
Clemens, Eva | 2016 | Determinants of irreverisible ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: a DCOG-LATER study | ESLCCC 2016, Copenhagen, Denmark |
Clemens, Eva | 2016 | Hearing loss after platinum-treatment is irreversible at long-term follow-up in non-cranial irradiated CCS, a DCOG study | ESLCCC 2016, Copenhagen, Denmark |
Teepen, Jop | 2016 | Chemotherapy-related risks of subsequent solid cancer, breast cancer, and sarcoma among childhood cancer survivors: a DCOG-LATER cohort study | ESLCCC 2016, Copenhagen, Denmark |
van de Loo, Laurence | 2016 | Uterine volume, pregnancy complications and pregnancy outcomes among female childhood cancer survivors treated with radiotherapy involving the uterus | ESLCCC 2016, Copenhagen, Denmark |
van den Berg, Marleen | 2016 | Effect of cancer and its treatment on ovarian function markers in long-term female survivors of childhood cancer | ESLCCC 2016, Copenhagen, Denmark |
van Dijk, Marloes | 2016 | Use and success rates of assisted reproductive techniques among female survivors of childhood cancer: results of the DCOG-LATER-VEVO study | ESLCCC 2016, Copenhagen, Denmark |
Teepen, Jop | 2015 | Subsequent colorectal adenomas in childhood cancer survivors: a DCOG-LATER record linkage study | ESTRO, Torino, Italia |
Clemens, Eva | 2015 | The influence of co-medication on platinum-related ototoxicity in long-term survivors of childhood cancer: a descriptive DCOG study | NASLCCC 2015, Arlington VA, USA |
Dulmen-Den Broeder, E | 2015 | Breastfeeding in dutch female survivors of childhood cancer | NASLCCC 2015, Arlington VA, USA |
Feijen, Lieke | 2015 | Incidence of symptomatic cardiac chronic health conditions and associated risk factors in a natwionwide dutch cohort of 5-year childhood cancer survivors; a DCOG-LATER study | NASLCCC 2015, Arlington VA, USA |
Kilsdonk, Ellen | 2015 | Overall and cause-specific late mortality in childhood cancer survivors: a DCOG-LATER cohort study | NASLCCC 2015, Arlington VA, USA |
Teepen, Jop | 2015 | Long-term risk of second malignant neoplasms among childhood cancer survivors: a DCOG-LATER cohort study | NASLCCC 2015, Arlington VA, USA |
van den Berg, M | 2015 | Uterine volume and blood flow in childhood cancer survivors treated with radiotherapy involving the uterus | NASLCCC 2015, Arlington VA, USA |
van den Berg, Marleen | 2015 | The value of anti-mullerian hormone, fsh, and inhibin b as measures of antral follicle count in childhood cancer survivors | NASLCCC 2015, Arlington VA, USA |
Teepen, Jop | 2014 | The long-term risk of SMNs and associated treatment-related and lifestyle risk factors in a large cohort of survivors of childhood cancer. | Amsterdam Kindersymposium, Amsterdam, The Netherlands |
Teepen, Jop | 2014 | Design of a nested case-control study to assess the radiation dose-response relationship for basal cell carcinoma in childhood cancer survivors: a DCOG-LATER study | Radiation and Health annual conference, Las Vegas, USA |
Ronkers, Cecile | 2013 | The DCOG-LATER study; a national collaboration of the late effects of childhood cancer task force of the dutch childhood oncology group | NASLCCC 2013, Memphis TN, USA |
Ronkers, Cecile | 2011 | The DCOG-LATER cohort of childhood cancer survivors in the Netherlands | ESLCCC 2011, Amsterdam, The Netherlands |
Tissing, Wim | 2011 | The DCOG-LATER Q2008 study: late effects in childhood cancer survivors in a naon-wide cohort in the Netherlands | ESLCCC 2011, Amsterdam, The Netherlands |
Kremer, Leontien | 2009 | The Dutch DCOG-LATER Group | ESLCCC 2009, Edinburgh, UK |
Ronkers, Cecile | 2007 | LATER: A nation-wide registry of 5-year survivors of childhood cancer in the Netherlands | ESLCCC 2007, Lund, Sweden |